n several murine tumour systems, expression of class II major histocompatibility complex (MHC) antigens by tumour cells, either constitutive or inducible, correlates with reduced tumorigenicity as compared with equivalent class-II-negative cells, and CD4 phenotype T cells together with interferon γ (which induces the expression of class II) may be involved in the control of the proliferation of class-II-expressing tumours. This implies a potential T-cell-mediated selection pressure against class II expression. To test this possibility, we have repeatedly passaged as tumours in euthymic, syngeneic miceras-transformed murine fibroblast lines, which are class-II-inducible, to determine whether class-II-non-inducible variants are selected. We e...
It was shown previously that combination therapy of tumor-bearing mice resulted in amplification of ...
Primary mouse cells transformed by adenovirus type 12 (Ad12) expressed negligible amounts of class I...
Purpose: We have shown previously that the MHC class II - negative murineTS/A adenocarcinoma is reje...
In several murine tumour systems, expression of class II major histocompatibility complex (MHC) anti...
Paired lines of C3H mouse fibroblasts transformed with murine sarcoma virus (Kirsten strain) were pr...
There is much evidence to suggest that potentially immunogenic tumour cells can escape cytolytic imm...
A number of viral genes and cellular oncogenes inhibit major histocompatibility complex (MHC) antige...
In previous reports, we have shown that adoptive transfer of tumor-sensitized T (immune) cells to tu...
We have previously found that an increased tumorigenicity and spontaneous metastatic potential of BW...
Objectives: The loss of major histocompatibility complex (MHC) classes I and II is a well-known mech...
Intratumor heterogeneity among cancer cells is promoted by reversible or irreversible genetic altera...
Class I and class II major histocompatibility complex (MHC) antigens are required for CD8+ cytotoxic...
Within tumors, immune responses strongly influence tumor development and stroma architecture, determ...
The expression of major histocompatibility complex (MHC) class II antigens is down-regulated when B ...
The ability of mice to mount a cytotoxic T-lymphocyte (CTL) immune response to SV40 T-antigen is det...
It was shown previously that combination therapy of tumor-bearing mice resulted in amplification of ...
Primary mouse cells transformed by adenovirus type 12 (Ad12) expressed negligible amounts of class I...
Purpose: We have shown previously that the MHC class II - negative murineTS/A adenocarcinoma is reje...
In several murine tumour systems, expression of class II major histocompatibility complex (MHC) anti...
Paired lines of C3H mouse fibroblasts transformed with murine sarcoma virus (Kirsten strain) were pr...
There is much evidence to suggest that potentially immunogenic tumour cells can escape cytolytic imm...
A number of viral genes and cellular oncogenes inhibit major histocompatibility complex (MHC) antige...
In previous reports, we have shown that adoptive transfer of tumor-sensitized T (immune) cells to tu...
We have previously found that an increased tumorigenicity and spontaneous metastatic potential of BW...
Objectives: The loss of major histocompatibility complex (MHC) classes I and II is a well-known mech...
Intratumor heterogeneity among cancer cells is promoted by reversible or irreversible genetic altera...
Class I and class II major histocompatibility complex (MHC) antigens are required for CD8+ cytotoxic...
Within tumors, immune responses strongly influence tumor development and stroma architecture, determ...
The expression of major histocompatibility complex (MHC) class II antigens is down-regulated when B ...
The ability of mice to mount a cytotoxic T-lymphocyte (CTL) immune response to SV40 T-antigen is det...
It was shown previously that combination therapy of tumor-bearing mice resulted in amplification of ...
Primary mouse cells transformed by adenovirus type 12 (Ad12) expressed negligible amounts of class I...
Purpose: We have shown previously that the MHC class II - negative murineTS/A adenocarcinoma is reje...